Purchase Order 75N92026P00036
- Not listed
- This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...
- This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of "Live Animals, Not Raised for Food" and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $56,300.00 firm fixed-price delivery order is for services including gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst injection,...
- This federal contract award is for Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $6,193.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is a delivery order for the production of gene knockout and gene knock-in male mice to be crossed with female...
- This federal contract award is for Task Order 19 under a broader Delivery Order contract with Ozgene PTY LTD, an Australian company providing genetically modified mice and related services in support of biomedical research. The $67,700.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract provides for services such as...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $24,686 firm fixed-price purchase order to Ozgene PTY LTD, an Australian genetic research company, on December 30, 2025. The contract, which carries no set-aside designation, is for the creation of a mouse colony breeding service to support NHLBI's biomedical research initiatives. The work will be performed in Boston, Massachusetts, with an ultimate completion date of December 29, 2026. Ozgene, headquartered in Bentley, Western Australia, brings specialized expertise in mouse model development and genetic engineering technologies essential for advanced cardiovascular and pulmonary research. Ozgene has established a track record as a preferred vendor for NIH institutes, with prior awards from NHLBI, the National Institute of Allergy and Infectious Diseases, and the National Institute of Diabetes and Digestive and Kidney Diseases for similar genetic research services. The company's contract awards have consistently focused on highly specialized deliverables including mouse colony breeding, gene targeting vector services, and the creation of genetically modified mouse models for biomedical investigation. This award represents a continuation of NHLBI's reliance on Ozgene's competitive capabilities to provide precise, customized genetic research services that directly support the Institute's research mission in cardiovascular, lung, and blood diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 12/30/25 |